{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-035783","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.669782+00:00","generated_at":"2026-05-31T05:31:28.729124+00:00","sec_items":["7.01","8.01","1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sanara invests $5M for 6.6% of ChemoMouthpiece, exclusive U.S. distribution via InfuSystem JV","bullets":["Sanara CMP purchased 100,674.72 common units in ChemoMouthpiece for $5.0 million, a 6.64% ownership stake.","SI Technologies (50/50 JV with InfuSystem) appointed sole U.S. distributor of ChemoMouthpiece kits for 5 years.","SI Technologies has an option to purchase ChemoMouthpiece's U.S. business, including IP, expiring Jan 31, 2029.","Sanara borrowed an additional $15.5M under its CRG term loan at 13.25% per annum, maturing May 30, 2029.","Proceeds used for the ChemoMouthpiece investment; remaining funds for acquisitions and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-035783","json":"https://secwatch.observer/filing/0001493152-24-035783.json","markdown":"https://secwatch.observer/filing/0001493152-24-035783.md","text":"https://secwatch.observer/filing/0001493152-24-035783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/0001493152-24-035783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:31:28.729124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}